The Impact of Coronary Ischemia Assessment on Outcomes in Those With Scar‐Dependent Ventricular Tachycardia
Journal of Cardiovascular Electrophysiology · 2025-01 · 36 (1) · 201-211
DOI: 10.1111/jce.16495 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cardiovascular Electrophysiology, online erschienen am 15.11.2024. Verfasst von Michael C Waight und 5 weiteren Autor:innen. Beteiligte Einrichtung: City St George's University of London, London, UK. Hauptthemen laut MEDLINE: Tachycardia, Ventricular, Cicatrix. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: St George's Hospital Charity.
Abstract (Originalsprache)
Background
Guidance and outcomes of coronary ischemia assessment (IA) in those with structural heart disease (SHD), presenting with monomorphic ventricular tachycardia (MMVT) is unclear.
Objectives
To assess the impact of IA on arrhythmic and non‐arrhythmic outcomes in those with SHD.
Methods
Patients presenting with MMVT over a 6‐year period to a tertiary center were retrospectively analyzed. Propensity score‐matched analysis was performed comparing those undergoing IA to those who did not. The primary endpoint was a composite of VT recurrence, appropriate ICD therapy, heart failure hospitalization, and death. Secondary analysis of the individual components of the composite was performed. Kaplan–Meier, univariate and multivariate analysis was performed to compare the two groups and derive predictors of poor outcomes.
Results
Two hundred and seventeen patients (57.6% ICM) were analyzed. 55.8% underwent IA. Following propensity score‐matching, 120 patients remained. At 12 months, freedom from the primary endpoint was 68.3% of those undergoing IA versus 43.3% who did not, p < 0.001, multivariate HR 0.56 (0.34–0.92). This was driven by a reduction in all‐cause mortality, with a 12‐month survival of 98.3% in those undergoing IA versus 86.5% in those not undergoing IA ( p < 0.01). Coronary intervention was associated with a significantly higher event‐free 12‐month survival compared to those who did not undergo intervention (82.4% vs 51.5%, respectively, p = 0.01).
Conclusions
Patients with SHD presenting MMVT who undergo an IA have significantly improved freedom from VT recurrence, appropriate ICD therapies, HF hospitalization, and death compared to those who do not, driven by a reduction in mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- City St George's University of London, London, UK.
- St George's University Hospitals NHS Foundation Trust, London, UK.
- Cleveland Clinic of London, London, UK.
ORCID-Profile: Michael C Waight, Davide Fabbricatore, Elijah R Behr, Manav Sohal, Anthony C Li, Magdi M Saba
Förderung
- St George's Hospital Charity
Zitieren
APA
Waight, M. C., Fabbricatore, D., Behr, E. R., Sohal, M., Li, A. C., & Saba, M. M. (2025). The Impact of Coronary Ischemia Assessment on Outcomes in Those With Scar‐Dependent Ventricular Tachycardia. Journal of Cardiovascular Electrophysiology, 36(1), 201-211. https://doi.org/10.1111/jce.16495
Vancouver
Waight MC, Fabbricatore D, Behr ER, Sohal M, Li AC, Saba MM. The Impact of Coronary Ischemia Assessment on Outcomes in Those With Scar‐Dependent Ventricular Tachycardia. Journal of Cardiovascular Electrophysiology. 2025;36(1):201-211. doi:10.1111/jce.16495
BibTeX
@article{Waight2025,
author = {Waight, Michael C and Fabbricatore, Davide and Behr, Elijah R and Sohal, Manav and Li, Anthony C and Saba, Magdi M},
title = {The Impact of Coronary Ischemia Assessment on Outcomes in Those With Scar‐Dependent Ventricular Tachycardia},
journal = {Journal of Cardiovascular Electrophysiology},
year = {2025},
volume = {36},
number = {1},
pages = {201--211},
doi = {10.1111/jce.16495}
}
EUVIMED